Featured Stories

Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.

Hari Om Aggarwal

It was the year 2002… Hari Om Agarwal, a businessman from Udhampur and a government suppli…

Sonali Dixit

My name is Sonali Dixit, and I want to share my long and arduous journey with pancreatitis. It&rs…




Noida, Uttar Pradesh

Shalini Garg

This story is a powerful testament to resilience and hope. It narrates the journey of Shalini Gar…

Rajeev Sharma

Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…




Dehradun, Uttarakhand

Robin Singh

This story narrates the journey of Robin Singh, a healthy, 30-year-old businessman and gym-goer, …




Kurukshetra, Haryana

Ananya

Ananya’s battle began at the age of 12 in 2013. What started as a routine Sunday stomach ac…




Bhadra, Hanumangarh, Rajasthan

All Stories

Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.

Hamad Alam

Rectal Adenocarcinoma




New Delhi

Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…

Patient Name

Acute Recurrent Pancreatitis




Kotdwar, Uttarakhand.

Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …

Anurag Goyal

Investment Banker




New Delhi

Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…

Sumit Kumar

Sumit Kumar

Pancreas Divisum with secondary Chronic Pancreatitis




Dehradun, Uttarakhand

Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…

Aviral Saxena

Aviral Saxena

Chronic Pancreatitis with Secondary Diabetes




Dehradun, Uttarakhand

Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …

Rajeev Sharma

Chronic Pancreatitis




Dehradun, Uttarakhand

Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…

Our Research

At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.

Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment

Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment

Acute promyelocytic leukemia (APML) is a subtype of leukemia marked by anemia, infections, and bleeding. It is diagnosed through bone marrow tests and the PML-RARα fusion gene. Recent treatments with ATRA and arsenic trioxide have improved survival rates, but challenges like side effects and relapses remain. A 1982 case of a patient who survived 37 years without standard treatment suggests potential alternative therapies.

Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis

Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis

Hereditary pancreatitis (HP) is a chronic genetic disorder with limited treatment options. This study evaluated the efficacy of a year-long Ayurvedic Treatment Protocol (ATP) in 151 patients, 88 of whom completed the program. The treatment included Ayurvedic formulations, dietary adjustments, and discontinuation of pancreatic enzymes. Results showed a 92.8% reduction in attack frequency and a 98.7% decrease in hospitalizations (p < 0.0001), with no adverse effects. ATP demonstrated safety and effectiveness in managing HP, suggesting the need for further research.

Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis

Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis

The study of 1233 acute pancreatitis patients found that 12.9% experienced oral feeding intolerance (OFI). Risk factors included younger age, male sex, alcohol use, smoking, non-biliary etiology, and SIRS at 48h. SIRS at 48h (OR 2.85) and non-biliary etiology (OR 1.77) were independently linked to OFI, with biliary etiology being protective.

Sustainable Effect of Ayurvedic Formulations in the Treatment of Nutritional Anemia in Adolescent Students

Sustainable Effect of Ayurvedic Formulations in the Treatment of Nutritional Anemia in Adolescent Students

This study evaluated the impact of Ayurvedic treatments (Sootshekhar Rasa and Sitopaladi Churna) on nutritional anemia in 1322 adolescent students in Dehradun. After 90 days of treatment, significant hemoglobin improvements were seen in the treatment groups, especially those receiving a daily dose of 250 mg SR and 400 mg SC. The study concluded that this combination effectively improves anemia in adolescents without adverse effects.

Hepato-protective Effect of an Ayurvedic Formulation Prak-20 in CCl 4 Induced Toxicity in Rats: Results of Three Studies

Hepato-protective Effect of an Ayurvedic Formulation Prak-20 in CCl 4 Induced Toxicity in Rats: Results of Three Studies

Prak-20, an ayurvedic herbo-mineral formulation, was studied for its hepato-protective effects in rats. It showed no significant liver damage or elevated enzyme levels compared to controls. In higher doses, it reduced liver enzymes by up to 54% and minimized liver damage. These results suggest Prak-20 is effective in protecting the liver, with further research needed on its mechanism.

Case studies on prophylactic ayurvedic therapy in migraine patients

Case studies on prophylactic ayurvedic therapy in migraine patients

Ayurvedic treatment has shown effectiveness in managing migraines. A protocol (ATP) with herbo-mineral formulations, regular meals, and sleep reduced migraine frequency and intensity in a study of nine patients. Five reported significant improvement after 120 days, with no serious side effects. Ongoing research is further validating the findings.